US and Global Clinical Trials
Citeline Connect Clinical Trial Recruitment Platform Announces Expansion of Reach into all Global Markets
20 oct. 2021 12h00 HE | Informa Business Intelligence
NEW YORK, Oct. 20, 2021 (GLOBE NEWSWIRE) -- Citeline Connect, the all-in-one clinical trial recruitment platform developed by Informa Pharma Intelligence, is expanding its technology and...
new-pharma300x111.jpg
Patients Rate their Clinical Trial Experience Positively, but Trial Locations Still Pose Barriers to Enrollment
27 juil. 2021 09h00 HE | Informa Business Intelligence
NEW YORK, July 27, 2021 (GLOBE NEWSWIRE) -- Informa Pharma Intelligence, the global business intelligence provider for the biopharma industry, released its first “Patient Perspectives on Clinical...
22157.jpg
Healthcare BPO Market by Outsourcing Models, Provider, Payer, Life Science and Region - Global Forecasts to 2026
26 juil. 2021 09h23 HE | Research and Markets
Dublin, July 26, 2021 (GLOBE NEWSWIRE) -- The "Global Healthcare BPO Market by Outsourcing Models, Provider (Patient Care, RCM), Payer (Claims Management, Billing & Accounts), Life Science...
Logo-uniQure-MS-Word_Orange.jpg
uniQure Announces Enrollment of First Two Patients in Second Cohort of Phase I/II Clinical Trial of AMT-130 for the Treatment of Huntington’s Disease
16 juin 2021 07h05 HE | uniQure Inc.
LEXINGTON, Mass. and AMSTERDAM, The Netherlands, June 16, 2021 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with...
22157.jpg
Global Clinical Trials Market Analysis Report 2021: Phase III Clinical Trials Dominated the Market with a Share of 53.2% in 2020 - Forecast to 2028
04 juin 2021 07h33 HE | Research and Markets
Dublin, June 04, 2021 (GLOBE NEWSWIRE) -- The "Clinical Trials Market Size, Share & Trends Analysis Report by Phase (Phase I, Phase II, Phase III, Phase IV), by Study Design (Interventional,...
Neovasc_Logo-web-header.jpg
Neovasc Announces First Patient Enrollment in COSIMA Trial
10 mai 2021 09h05 HE | Neovasc, Inc.
VANCOUVER and MINNEAPOLIS, May 10, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire ‒ Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today announced that the first patient has been enrolled...
22157.jpg
World Virtual Clinical Trial Service Providers Market 2020-2025, by Type of Therapeutic Area, End-Users, Phase of Development and Key Geographies
27 avr. 2021 08h38 HE | Research and Markets
Dublin, April 27, 2021 (GLOBE NEWSWIRE) -- The "Virtual Clinical Trial Service Providers Market by Type of Therapeutic Area, End-Users, Phase of Development (Phase I, Phase II, Phase III and Phase...
22157.jpg
Data Science Impacting the Pharmaceutical Industry, 2020 Report: Focus on Clinical Trials - Data Science-driven Patient Selection & FDA Accelerated Data Sharing has Opened Many Opportunities
10 févr. 2021 04h18 HE | Research and Markets
Dublin, Feb. 10, 2021 (GLOBE NEWSWIRE) -- The "Data Science Impacting the Pharmaceutical Industry Part II: Clinical Trial Applications" report has been added to ResearchAndMarkets.com's offering. ...
Phathom_Pharm_Logo_RGB.jpg
Phathom Pharmaceuticals Announces Completion of Patient Enrollment in Pivotal Phase 3 Helicobacter pylori (H. pylori) Trial
19 janv. 2021 08h30 HE | Phathom Pharmaceuticals
Topline results expected in second quarter of 2021NDA submission for H. pylori expected in second half of 2021 FLORHAM PARK, N.J., Jan. 19, 2021 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals,...
American BriVision Announces Completed Patient Enrollment in Clinical Trial at UCSF for Treatment of Adult ADHD
15 juin 2020 09h00 HE | American BriVision Holding Corporation
Patient enrollment has been completed for a Phase II Part I clinical trial at the University of California, San Francisco (UCSF) Medical Center Primary objective of Phase II Part I clinical trial is...